CBD oil is an oil made from cannabidiol, which is a chemical compound found within the cannabis plant.
Cannabidiol is non-psychoactive and has recently been hailed for having various health benefits, such as for the treatment of epilepsy.
In a recent study, CBD oil was found to “significantly” improve the symptoms of Crohn’s disease and the quality of life of sufferers who have the disease, but contrary to previous medical thinking, has no effect on gut inflammation.
Sativa Investments (NEX:SATI) seeks to invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.